semaglutide ban A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Compounded Semaglutide Manufacturing Ban
Description
Retatrutide is supplied strictly for laboratory research use only
Dispatches upon release
Try Good Idea drinks today
Discover science-backed methods to lock in weight loss, maintain metabolic changes, and avoid common pitfalls after GLP-1 therapy ends
2021;14(1):137
